Skip to main content
Ad Scientiam
Back to previous page
Press release

MSCopilot® receives CE marking under EU Regulation

June 12, 2025

MSCopilot® receives CE marking

MSCopilot®, our Class IIa digital medical device for monitoring people living with multiple sclerosis (MS), has received CE marking under European Regulation (EU) 2017/745 for medical devices.

This certification recognizes the safety, performance, and clinical benefit of our digital solution, the result of more than 10 years of clinical research, conducted with expert centers and committed industry partners.

This is an important milestone for people with MS, but also for their loved ones and the healthcare professionals who support them daily.

Share this news with your network

Accelerate your clinical studies and improve the monitoring of your patients

Talk to our experts and discover how our solutions integrate into your practice or studies.

Ad Scientiam

Digital Village, 21-23 Rue Albert Bayet, 75013 Paris

contact@adscientiam.com

About us

Our Solutions

Contact us

Our news